Loading stock data…
$118.59-0.21 (-0.18%)
Paychex, Inc., together with its subsidiaries, provides human capital management solutions (HCM) for human resources, payroll processing, employee benefits, and insurance services for small to medium-sized businesses in the United States, Europe, Canada, India, and Israel.
Paychex, Inc. in the Technology sector is trading at $118.59 with a market capitalization of $42.0B. Wall Street consensus targets $113.93 (14 analysts), implying a -3.9% move over the next 12 months. The stock is currently 7% below its 52-week high of $127.98, remaining 16.1% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.61B↓ | $1.81B↑ | $1.56B↑ | $1.54B↑ | $1.43B |
| Gross Profit | $1.19B↓ | $1.38B↑ | $1.15B↑ | $1.13B↑ | $1.03B |
| Operating Income | $604.70M↓ | $792.00M↑ | $571.90M↑ | $541.90M↑ | $431.10M |
| Net Income | $420.60M↓ | $560.30M↑ | $395.40M↑ | $383.80M↑ | $297.20M |
Paychex, Inc., together with its subsidiaries, provides human capital management solutions (HCM) for human resources, payroll processing, employee benefits, and insurance services for small to medium-sized businesses in the United States, Europe, Can...
Academic risk and quality models computed from PAYX's own filings and price history, not from analyst opinion.
Strong on 7 of 9 fundamental-health tests covering profitability, leverage and operating efficiency.
Altman Z above the 2.99 safe threshold, so the model puts bankruptcy risk in its lowest band.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
GARCH(1,1) 30-day annualised forecast, above the current 31.9% reading.
Fama-French 5-factor market beta. The five factors explain 15% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-10-22.